How Canadian medical and healthcare clinics can finance diagnostic and lab equipment
Short answer: Most Canadian clinics are better off leasing diagnostic and lab equipment over its useful life and using separate working capital tools for reagents, staffing, and renovations. In practice, that means a mix of equipment leases, asset-based lending, and sale–leaseback for analyzers and imaging hardware — backed by working capital loans and lines of credit — instead of draining cash or relying on short-term, high-cost credit.
Why diagnostic and lab equipment is a financing problem, not just a clinical one
Canadian clinics are under pressure from every direction: patients want faster answers, governments want shorter wait lists, and technology keeps leaping forward. The result is a steady need for new diagnostic and lab equipment — and a constant battle to pay for it.
Canada’s medical device market was estimated at US$6.8 billion in 2022, and is expected to grow by about 5.4% annually to 2028. Diagnostic imaging devices alone are projected to rise from about US$1.06 billion in 2024 to US$1.39 billion by 2032.
At the same time, capacity still lags demand: the Canadian Medical Imaging Inventory reports that MRI units have increased by over 27% since 2015, but MRI waits remain above recommended targets in many provinces, and CT/MRI wait times have lengthened compared with pre-pandemic periods. That gap is pushing more diagnostic volume toward community clinics, independent health facilities, and private labs.
The problem is that the tools to fix this — analyzers, imaging systems, robotics, even sophisticated point-of-care devices — are expensive and upgrade-prone. Clinics face:
- Six-figure costs for imaging systems and analyzers
- Ongoing spend on upgrades, software, and interfaces
- Multi-year ROI timelines tied to referral patterns and payer rules
Most practices can’t (and shouldn’t) pay for that in cash. The smarter play is to design a capital plan that uses equipment-focused financing for the machines and separate facilities for day-to-day operations.
That’s where a specialist such as Mehmi comes in, with equipment financing programs built for Canadian clinics and lab operators.
Core principle: match long-life diagnostic assets to long-term, asset-backed financing
Key idea: If a piece of diagnostic or lab equipment will earn revenue and support care for 5–10 years, it shouldn’t be funded with 6–18-month cash-flow products or maxed cards.
BDC describes equipment financing as a way to fund “tangible long-term assets that can benefit your business over several years of use,” usually secured by the equipment itself. That’s exactly what diagnostic and lab equipment is:
- Long-life, high-impact capital assets
- With clear serial numbers and resale value
- That can often serve as their own collateral
So the starting point for most clinics should be:
- Use equipment-specific facilities for analyzers, imaging devices, and major instruments.
- Keep lines of credit and working capital for reagents, supplies, staffing, and renovation.
- Avoid mixing permanent assets with short-term needs in one “do-everything” loan — that’s how clinics end up over-levered and still short of cash.
Mehmi’s toolkit — from equipment leases to asset based lending and refinancing or sales leaseback — is built around that principle.
Equipment leases: the backbone of diagnostic and lab financing
Key idea: Leasing turns large upfront equipment costs into predictable monthly payments over the asset’s useful life, while keeping your cash in the clinic.
What kinds of diagnostic and lab equipment can be leased?
If it has a serial number, holds resale value, and is integral to care, there’s a good chance it fits Mehmi’s eligible equipment criteria. Typical examples:
Imaging & diagnostic
- Ultrasound, digital X-ray, DR panels
- C-arms, mammography units
- Cone-beam CT (CBCT) for dental and ENT
- ECG/Holter, cardiology testing systems
Lab and diagnostics
- Hematology and chemistry analyzers
- Immunoassay platforms
- PCR and molecular analyzers
- Coagulation and microbiology instruments
- Specimen processors, centrifuges, refrigerators, freezers
Clinic & specialty devices
- Dental and endodontic units
- Ophthalmic and optometry equipment
- Aesthetic and dermatology devices
- Point-of-care testing (POCT) carts and devices
A Mehmi equipment lease lets you:
- Acquire equipment with minimal upfront cash
- Align payments with expected patient volumes and reimbursement levels
- Plan for upgrades at the end of term, instead of hanging onto obsolete devices
Practically, it’s how many clinics in Canada keep up with a medical device market that’s growing and constantly innovating.
Why leasing often beats buying outright
Some physicians instinctively want to “own” everything. But there are good reasons leasing dominates medical equipment finance globally:
- Cash flow: You preserve cash for rent, payroll, marketing, and unforeseen events — instead of tying it up in metal and plastic.
- Tech obsolescence: For fast-moving areas like imaging, endoscopy, and lab diagnostics, technology cycles can be shorter than the physical life of the machine. Leasing lets you plan upgrades sensibly.
- Tax treatment: Instead of tracking CCA on every purchase, lease payments are often treated as operating expenses (your accountant will confirm how this plays out for your structure).
- Collateral: Lenders take security in the equipment itself, not automatically in your house or building.
From Mehmi’s side, equipment leases are usually the first tool they reach for with diagnostic and lab deals.
Asset-based lending and sale–leaseback: using existing equipment to fund the next upgrade
Key idea: If you already own solid diagnostic or lab equipment, you may be sitting on the collateral you need to modernize — without pulling from cash or personal lines.
Asset-based lending on your diagnostic and lab portfolio
With asset based lending (ABL):
- A lender advances a percentage of the orderly liquidation value of your equipment (imaging, analyzers, specialty gear).
- The facility is secured by that asset base rather than just general cash flow.
- You can use funds to:
- Buy new equipment;
- Consolidate older loans;
- Finance renovations or digital upgrades.
This works well for multi-site clinics and labs that have built up equipment over time but are now facing a large modernization step — for example, moving to newer analyzers, adding digital systems, or expanding to a second location.
Refinancing and sales leaseback to unlock equity
A refinancing or sales leaseback is a more targeted move:
- A funding partner buys some of your existing equipment at an agreed value.
- You lease the equipment back and keep using it in the clinic.
- You receive a lump sum that can be used to:
- Pay out expensive loans or credit-card balances used during a tight period.
- Fund new analyzers or devices (e.g., adding molecular diagnostics).
- Build a buffer for staffing or marketing as you expand services.
This is especially powerful when:
- You previously bought equipment in cash,
- Your practice has weathered a tough year or two, and
- You now need capital to expand diagnostics or add in-house lab capabilities that keep patients in your ecosystem.
Mehmi sees this often with clinics that added equipment during COVID on whatever terms were available — and now want to move to a more professional, sustainable structure.
Pairing equipment financing with working capital for reagents, consumables, and ramp-up
Key idea: Diagnostic and lab equipment doesn’t work without reagents, staff, and systems. Equipment should sit on long-term structures; the rest should live on flexible working-capital tools.
Capital outlay is only part of the story. When you add diagnostic or lab equipment, you also commit to:
- Reagents, controls, and consumables
- Quality control and proficiency testing costs
- Service contracts and software licenses
- Additional technologist or nursing hours
- Launch marketing to referrers and patients
If you try to bundle all of that into one big equipment deal, two things happen:
- Payments can get uncomfortably high.
- Lenders look at the “soft cost” portion and price your whole facility for that risk.
A cleaner approach is to layer in Mehmi’s business loans:
- A working capital loan for a defined ramp-up period (e.g., the first 12–24 months of a new lab or diagnostic service).
- A line of credit to handle timing gaps between performing tests and getting paid by insurers, provincial plans, or corporate clients.
- Invoice or freight factoring if you’re dealing with big corporate or institutional payors on 30–90-day terms.
For larger practices with real estate or a large equipment base, a secured loan might support a broader expansion; for smaller projects, a modest unsecured loan can plug specific gaps like training or software.
One thing I’m strongly against in a clinic setting: using high-cost merchant cash advances for long-term investments in analyzers or imaging. The effective rates in that market can be many times higher than standard loan or lease financing, and clinics already face enough pressure from payer rules and changing demand.
Tax and accounting angles: how CRA treats diagnostic and lab equipment
Key idea: Whether you buy or lease affects how you claim expenses and depreciation. Good financing plus smart tax planning can materially reduce your net cost.
The Canada Revenue Agency’s Capital Cost Allowance (CCA) system decides how you depreciate purchased equipment:
- Class 12 (100%) – small tools and medical or dental instruments under $500 can often be fully written off in the year of purchase.
- Class 8 (20% declining balance) – most larger medical and lab equipment, furniture, and fixtures fall into this “catch-all” category.
A practical example from a tax advisory firm: medical equipment worth $100,000 in Class 8 generates $10,000 of CCA in the first year because of the half-year rule — timing your purchase can change which tax year gets that deduction.
If you purchase diagnostic or lab equipment, you:
- Add it to the appropriate CCA class (often Class 8).
- Deduct CCA annually plus any interest expense on financing.
If you lease equipment, the lease payments themselves are often deductible as operating expenses, and you don’t track the asset on your balance sheet the same way (exact treatment depends on your accounting framework and lease type).
The right answer depends on your corporate structure and income profile — it’s always worth getting your accountant involved before a big modernization project. Mehmi can help you model payments with their calculator while your tax advisor optimizes CCA.
Building a financing plan for your next diagnostic or lab upgrade
Key idea: Treat diagnostic and lab upgrades as a capital project with a financing strategy, not as a shopping trip where you worry about money after you fall in love with a device.
Here’s a practical step-by-step plan.
Step 1: Clarify the clinical and business case
Before you look at catalogues:
- What patient or referrer problem are you solving?
- Shortening wait times?
- Bringing tests in-house to keep revenue?
- Expanding into new services (e.g., cardiology, women’s health, molecular)?
- How many additional tests per month are realistic, based on your catchment and payer mix?
CIHI’s data on persistent diagnostic wait times makes a strong case that additional capacity has value, but you still need a clinic-level plan, not just national statistics.
Step 2: Map the full project cost
Include all of it:
- Equipment (hardware, software, options)
- Installation, calibration, and certification
- Construction / leasehold improvements
- IT integration (EMR, LIS, PACS, RIS)
- Training, launch marketing, and extra staffing
This is where clinics often under-budget and later reach for painful, last-minute financing tools.
Step 3: Decide what goes on equipment financing vs working capital
As a rough rule:
- Equipment facilities
- Core analyzers and lab instruments
- Imaging and diagnostic devices
- Major specimen storage and processing equipment
→ Fund with equipment leases, possibly via an equipment line of credit if you’re upgrading in phases. - Working-capital facilities
- Reagents, consumables, and extra inventory
- Renovations that don’t qualify for equipment financing
- Staff ramp-up and marketing
→ Fund with working capital loans and lines of credit.
Step 4: Look at existing equipment as a funding source
List all your current major devices with approximate values and balances. See whether:
- You have paid-off analyzers or imaging systems with equity in them.
- Some older equipment could support asset-based lending or a sale–leaseback to free capital for the new project.
This is where Mehmi’s refinancing or sales leaseback can be the difference between “we can’t afford it” and “we can phase this in sensibly.”
Step 5: Model payments before signing vendor contracts
Use Mehmi’s calculator to test:
- Different term lengths for leases and loans
- A conservative vs aggressive volume ramp-up
- The impact of combining equipment payments with your existing obligations
If the plan only works with best-case assumptions, resize it. It’s better to start with a smaller analyzer and upgrade later than to over-commit and starve the clinic of cash.
Step 6: Get pre-approved and coordinate with your bank
Before you sign:
- Have Mehmi look at your plan and existing banking relationships.
- Make sure your bank’s general security agreement doesn’t block the new financing.
- Use Mehmi’s vendor program where it makes sense, so suppliers get paid cleanly and you keep flexibility on term and structure.
When you’re ready, the simplest way to start is to share your plans through Mehmi’s Contact Us page and have a Canadian credit specialist walk through options with you.
Anonymous case study: Ontario multi-site clinic group builds an in-house lab
Profile (details changed for privacy)
- Group of three family/urgent care clinics in Ontario
- Mix of provincially insured and private services
- Historically sent all lab work to external labs, with thin margins on collection fees
The challenge
The group wanted to:
- Add an in-house core lab at their largest site (hematology, chemistry, limited immunoassay).
- Offer rapid tests for key conditions to improve care and patient satisfaction.
- Eventually extend lab services to the other clinics and local physicians.
Capex for analyzers, specimen handling, refrigeration, and IT integration was quoted just over $700,000, plus construction and staffing. The physicians were wary of:
- Tying up personal lines and home equity
- Over-leveraging the corporation with one big term loan
The financing strategy with Mehmi
Working with a Mehmi advisor, they used a layered approach:
- Core analyzers on equipment leases
- Hematology, chemistry, and immunoassay analyzers, plus key specimen processing gear, were financed through equipment leases.
- Terms matched expected analyzer life and vendor support agreements.
- Sale–leaseback on existing diagnostic equipment
- The clinics had previously purchased ultrasound and ECG equipment in cash.
- Mehmi arranged a refinancing or sales leaseback on those devices, freeing capital to cover part of the lab construction.
- Working capital loan for ramp-up
- A two-year working capital loan funded reagents, QC programs, and additional lab technologist salaries while test volumes grew.
- Line of credit for receivables timing
- A modest line of credit smoothed timing differences between performing tests and billing provincial and private payors.
Results 18 months later
- Turnaround times improved significantly, which helped physician recruitment and patient satisfaction.
- The group captured lab revenue that used to leave the building, improving overall margins.
- Debt service rose, but payments were aligned with asset life and lab volumes — and the physicians kept their homes out of the security package.
They didn’t “find a cheap loan.” They built a coherent capital structure around the diagnostic and lab equipment they needed to grow.
FAQ: Financing diagnostic and lab equipment for Canadian clinics
1. Is it better to lease or buy diagnostic and lab equipment?
For most clinics, leasing is the better default. A Mehmi equipment lease spreads the cost of analyzers and devices over their useful life, keeps cash available for staffing and rent, and provides more flexibility when technology changes. Buying outright can make sense once you’re very stable and cash-rich, but for growth-minded clinics, tying up capital in machines usually creates more risk than it removes.
2. Can small clinics finance diagnostic or lab equipment, or is this only for hospitals?
Small and mid-sized clinics are a major part of Canada’s medical device market, which totals roughly US$6.8 billion and is dominated by SMEs. Specialist funders like Mehmi work with independent clinics, imaging centres, and labs every day. The key is to show realistic volumes, a solid business case, and a structure that matches your size — not to look like a hospital on paper.
3. Can refurbished diagnostic and lab equipment be financed?
Often yes. Refurbished analyzers and imaging devices can be financeable if:
- They come from reputable vendors with warranties or service support.
- Age, condition, and technology generation are acceptable.
- They fall under Mehmi’s eligible equipment criteria.
In many cases, clinics blend refurbished platforms with a lease or asset based lending to get more capability for the same budget.
4. Can we refinance existing lab or imaging equipment to fund upgrades?
Yes. If you own devices outright or are close to paying them off, refinancing or sales leaseback can unlock equity while you keep using the equipment. Combined with new equipment financing and a tailored working capital loan, this can fund significant upgrades without draining cash or leaning on personal borrowing.
5. How does CRA treat medical and lab equipment for tax purposes?
Most larger diagnostic and lab equipment is treated as Class 8 property with a 20% declining-balance CCA rate, while many small tools and instruments under $500 fall into Class 12 with 100% deductibility in the year of purchase. Lease payments are typically deductible as operating expenses instead, depending on your structure and accounting method. The best mix of buying vs leasing depends on your income and plans — Mehmi handles the financing, and your accountant optimizes CCA.
6. When should we talk to Mehmi instead of just our bank or vendor?
Your bank and vendors are important partners, but they usually see only one piece of the puzzle. It makes sense to talk to Mehmi when:
- You’re planning a significant diagnostic or lab expansion in the next 6–24 months.
- You already have multiple loans or leases and want to restructure into a cleaner, asset-based picture.
- You need a mix of equipment financing and business loans (for reagents, IT, and staffing) under one coherent plan.
You can start that conversation anytime through Mehmi’s Contact Us page, or explore sector insights via the blog and industries pages.
Internal links used (list)
External citations used (list)
- U.S. International Trade Administration, Canada – Medical Devices – Canadian medical device market size (US$6.8B in 2022) and expected 5.4% annual growth to 2028.
- Credence Research, Canada Diagnostic Imaging Devices Market – projected growth of diagnostic imaging devices from US$1.06B in 2024 to US$1.39B by 2032.
- Canadian Medical Imaging Inventory (CMII) / NCBI, Canadian Medical Imaging Inventory 2022–2023: MRI – 27.1% increase in MRI units since 2015 and MRI wait times remaining above recommended targets.
- CIHI, Wait Times for MRI Scan and Wait times for priority procedures in Canada, 2024 – MRI and CT wait-time indicators and post-2019 changes.
- CIHI, Longer wait times for surgeries and diagnostic imaging persist across Canada – continued delays in diagnostic imaging relative to 2019.
- Government of Canada / CRA, Capital cost allowance (CCA) classes and rates and related guidance – treatment of Class 8 (20%) and Class 12 (100%) property, including medical tools and equipment.
- K.K. Chartered Professional Accountants, Understanding Canada’s Capital Cost Allowance – practical example of Class 8 medical equipment depreciation and half-year rule.
- BDC, Equipment financing 101: Everything you need to know and How to build your equipment financing proposal – defining equipment financing as funding for long-term tangible assets, secured by the equipment.
- Fincap, Remington Medical, DLL, MediCapital – examples of Canadian and global medical equipment leasing providers emphasizing cash-flow benefits, technology refresh, and tailored healthcare financing.
.avif)
.svg){kind=small}